Ghana vs Namibia: HIV/AIDS deaths averted by antiretroviral therapy
Ghana
12,358 deaths
in 2024
Namibia
11,508 deaths
in 2024
Ghana rank
20th
Namibia rank
22nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Ghana
- Namibia
How they compare
Ghana currently reports 12,358 deaths against 11,508 deaths in Namibia, a difference of 850 deaths.
That makes Ghana's figure about 1.1 times Namibia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Namibia ahead.
Ghana ranks 20th and Namibia ranks 22nd of 157 countries.
Across the 4 decades both report, Ghana averaged higher in 1 and Namibia in 2.
Head to head by decade
| Decade | Ghana | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,525 deaths | 3,179 deaths | 1,654 deaths | Namibia |
| 2010s | 9,063 deaths | 10,813 deaths | 1,750 deaths | Namibia |
| 2020s | 11,466 deaths | 11,415 deaths | 51.62 deaths | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Ghana or Namibia?
- Ghana, at 12,358 deaths against 11,508 deaths in Namibia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Ghana and Namibia?
- 850 deaths, with Ghana ahead.
- How many years of comparable data are there for Ghana and Namibia?
- 35 years are reported by both, from 1990 to 2024.
- How do Ghana and Namibia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Ghana ranks 20th and Namibia ranks 22nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.